Stay updated with breaking news from Mesangial Cell Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace
Share: Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the granting of a National Institutes of Health ("NIH") award to the University of California San Diego School of Medicine for the proposal entitled, "Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept." The award (Project Number: 1R01DK127201-01), from the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH, was granted to Co-Principal Investigators UC...